Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sunitinib Rechallenge in Patients With Metastatic Renal Cell Carcinoma.
Nachbargauer S, Bruchbacher A, Fajkovic H, Remzi M, Schmidinger M. Nachbargauer S, et al. Among authors: bruchbacher a. Clin Genitourin Cancer. 2020 Jun;18(3):e277-e283. doi: 10.1016/j.clgc.2019.11.006. Epub 2019 Dec 4. Clin Genitourin Cancer. 2020. PMID: 31902715 Clinical Trial.
PD1/PD-L1 therapy in metastatic renal cell carcinoma.
Bruchbacher A, Lemberger U, Hassler MR, Fajkovic H, Schmidinger M. Bruchbacher A, et al. Curr Opin Urol. 2020 Jul;30(4):534-541. doi: 10.1097/MOU.0000000000000788. Curr Opin Urol. 2020. PMID: 32453005 Review.
Systemic therapy for metastatic renal cell carcinoma in the first-line setting: a systematic review and network meta-analysis.
Mori K, Mostafaei H, Miura N, Karakiewicz PI, Luzzago S, Schmidinger M, Bruchbacher A, Pradere B, Egawa S, Shariat SF. Mori K, et al. Among authors: bruchbacher a. Cancer Immunol Immunother. 2021 Feb;70(2):265-273. doi: 10.1007/s00262-020-02684-8. Epub 2020 Aug 5. Cancer Immunol Immunother. 2021. PMID: 32757054 Free PMC article.
First-line Immunotherapy-based Combinations for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis.
Quhal F, Mori K, Bruchbacher A, Resch I, Mostafaei H, Pradere B, Schuettfort VM, Laukhtina E, Egawa S, Fajkovic H, Remzi M, Shariat SF, Schmidinger M. Quhal F, et al. Among authors: bruchbacher a. Eur Urol Oncol. 2021 Oct;4(5):755-765. doi: 10.1016/j.euo.2021.03.001. Epub 2021 Mar 20. Eur Urol Oncol. 2021. PMID: 33757737 Review.
Molecular and Pharmacological Bladder Cancer Therapy Screening: Discovery of Clofarabine as a Highly Active Compound.
Ertl IE, Lemberger U, Ilijazi D, Hassler MR, Bruchbacher A, Brettner R, Kronabitter H, Gutmann M, Vician P, Zeitler G, Koren A, Lardeau CH, Mohr T, Haitel A, Compérat E, Oszwald A, Wasinger G, Clozel T, Elemento O, Kubicek S, Berger W, Shariat SF. Ertl IE, et al. Among authors: bruchbacher a. Eur Urol. 2022 Sep;82(3):261-270. doi: 10.1016/j.eururo.2022.03.009. Epub 2022 Apr 4. Eur Urol. 2022. PMID: 35393162 Free article.
15 results